简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Benzinga Pro's Top 5 Stocks to Watch For Friday, May 13, 2022: TWTR, OTRA, AEO, DEA, AIKI

2022-05-13 20:42

Today's 5 Stock Ideas:

  • Twitter (TWTR) - Shares fell as much as 27% in pre-market action following a tweet from Elon Musk that said his deal for Twitter was "temporarily on hold." A couple hours later, Musk tweeted again and said he was still committed to the deal. While Twitter shares rebounded to over the $40 level following the second tweet, the stock was still down about 12% ahead of the open.

  • OTR Acquisition Corp. (OTRA) - A special purpose acquisition corporation (SPAC) redemption play for Friday and likely next week. A tweet highlighted "shareholders approved Comera Life Sciences deal, 10.3 million shares (98.4%) redeemed, leaving only 168k shares remaining." Benzinga writer and SPAC expert, Chris Katje, said the approved vote led to "one of the biggest redemptions ever."

  • American Eagle Outfitters (AEO) - A retailer with a decent dividend yield. The company's current $0.18/share quarter dividend yields about 3.5%.

  • Easterly Government Properties (DEA) - A play on a property owner for US government buildings (such as the Federal Bureau of Investigation, Drug Enforcement Agency and Central Intelligence Agency). CNBC "Fast Money: Halftime Report" contributor and Gilman Hill manager Jenny Harrington on Thursday highlighted this stock as a play on a higher interest rate market.

  • AIkido Pharma (AIKI) - On Thursday, the company announced it secured an interest in data and AI company, Databricks.

 

Benzinga programming note: we've started a podcast for the Stocks To Watch alert! Click here to see all the episodes.

Hosted by the Benzinga Pro newsdesk's Brent Slava and Steve Krause, the podcast will give more in-depth information on the ideas presented in the daily Stocks To Watch alert!

Listeners can find the podcast on Spotify and Apple by searching "Benzinga Stocks To Watch."

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。